Hinge Health Surges 53% in Q3, Lifts 2025 Forecast

On November 5, 2025, Hinge Health, Inc. (NYSE:HNGE) reported a standout Q3 performance, with revenue surging 53% year-over-year to $154.2 million, comfortably exceeding analyst expectations. The strong results were driven by yield improvements and efficiency gains in the company's care delivery model, which flowed through to a robust 93.4% incremental margin on adjusted operating income.

Hinge Health, a leading digital musculoskeletal clinic, provides personalized physical therapy and pain management programs through a combination of wearable sensors, app-based coaching, and licensed clinical care. The company's Q3 beat and raised guidance have further bolstered its position as one of the best digital health stocks to buy now.

Looking ahead, Hinge Health guided Q4 revenue to $155-$157 million, well above the Street's estimate of around $145.5 million. The company also raised its full-year 2025 revenue outlook to $572-$574 million, up from the previous consensus of $550.6 million. Analysts believe the current yield trajectory still appears conservative relative to these updated targets, with the company's innovative approach to care delivery continuing to drive impressive results.